Weiss Ratings Daily

On Monday, the investing world finally saw the filing for what some might argue as the most anticipated IPOs of the past few years. After seeing Facebook (Nasdaq: FB, Rated “B”), Lyft, Inc....

The headlines — shocking and scary — tell the story: COVID, coast to coast. It’s spreading everywhere — everywhere, it seems, except one eight-block enclave in Lower Manhattan ... “America Locks...

Monumental events are defining this month: The winner of the highest office in the land has been declared and there’s a viable COVID-19 vaccine potentially coming soon — welcome news as our nation...

TODAY AT 2 p.m. Eastern: URGENT CANNABIS INVESTOR BRIEFING with Senior Analyst Sean Brodrick and Founder Martin Weiss. For your free ticket, be sure to click here before 12 noon!  This...

Coronavirus cases in this country topped 11 million over the weekend, making today’s news from Moderna, Inc. (Nasdaq: MRNA) that much more significant. The pharmaceutical company announced its...

When I was a 30-year-old newbie retail stockbroker at Merrill Lynch, I thought I knew everything. You couldn’t tell me anything. But looking back, the only thing I really knew was the sales jargon...

I’ve said it before, and I’ll say it again … you can absolutely lose your mind by trying to follow the news these days. That’s even more true if you’re trying to use the news as a resource to time...

Is a “big shift” at hand? That’s the question Wall Street is wrestling with here. And, naturally, the answer will have major implications for investors. Before I offer my answer to that...

It’s not a bold-sentence recommendation, and it’s based on an interview conducted by a journalist for a different media outlet. It’s Jon Markman, writing in the Aug. 10 issue of Pivotal Point: ...

The stock market is surging dramatically this morning, celebrating the U.S. election and an announcement by Pfizer that its COVID-19 vaccine is 90% effective. But I don’t envy Joe Biden. More...